裘馨氏肌肉萎縮症:全球臨床實驗檢討

本報告提供全球各國裘馨氏肌肉萎縮症的臨床實驗的相關調查，彙整各地區、進展狀況、各階段、各募集情況的實驗量，代表性贊助商，正在開發的治療藥物的資訊，各企業機關的進行狀況等資訊，為您概述為以下內容。

目錄

目錄

• 表格一覽
• 圖表一覽
• 簡介
• 裘馨氏肌肉萎縮症
• 報告指南
• 臨床實驗 各地區
• 臨床實驗 各國
• 對臨床實驗有所貢獻的前幾名國家 - 亞太地區
• 對臨床實驗有所貢獻的前五國 - 歐洲
• 對臨床實驗有所貢獻的前幾名國家 - 北美
• 對臨床實驗有所貢獻的前幾名國家 - 中東及非洲
• 對臨床實驗有所貢獻的前幾名國家 - 中南美
• 臨床實驗 - 金磚四國 各國
• 臨床實驗 - G7 各國
• 臨床實驗 - G7 各國 各臨床實驗狀態
• 臨床實驗 - E7 各國
• 臨床實驗 - E7 各國 各臨床實驗狀態
• 臨床實驗 各階段
• 進行中的臨床實驗 各階段
• 臨床實驗 各臨床實驗狀態
• 未完成的臨床實驗; 裘馨氏肌肉萎縮症
• 每段時期的實驗人數
• 有力的贊助商
• 前幾名參與企業 - 裘馨氏肌肉萎縮症 治療藥物的臨床實驗
• 潛力治療藥物比較
• 臨床實驗簡介
• 臨床實驗概要; 前幾名企業
• PTC Therapeutics, Inc.
• 臨床實驗概要; PTC Therapeutics, Inc.
• Santhera Pharmaceuticals Holding AG
• 臨床實驗概要; Santhera Pharmaceuticals Holding AG
• GlaxoSmithKline plc
• 臨床實驗概要; GlaxoSmithKline plc
• Genethon
• 臨床實驗概要; Genethon
• AVI BioPharma Inc.
• 臨床實驗概要; AVI BioPharma Inc.
• Acceleron Pharma, Inc.
• 臨床實驗概要; Acceleron Pharma, Inc.
• Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
• 臨床實驗概要; Hugo W． Moser Research Institute at Kennedy Krieger, Inc.
• Prosensa Therapeutics B.V.
• 臨床實驗概要; Prosensa Therapeutics B．V.
• Children's Healthcare of Atlanta Inc.
• 臨床實驗概要; Children's Healthcare of Atlanta Inc.
• 臨床實驗概要; 最高級大學 / 研究機關 / 醫院
• Kobe University
• 臨床實驗概要; Kobe University
• Nationwide Children's Hospital
• 臨床實驗概要; Nationwide Children's Hospital
• Assistance Publique - Hopitaux de Paris
• 臨床實驗概要; Assistance Publique - Hopitaux de Paris
• Cincinnati Children's Hospital Medical Center
• 臨床實驗概要; Cincinnati Children's Hospital Medical Center
• 鈴鹿回生醫院
• 臨床實驗概要; 鈴鹿回生醫院
• 刀根山醫院
• 臨床實驗概要; 刀根山醫院
• INSTITUT DE RECHERCHES INTERNATIONALES SERVIER
• 臨床實驗概要; INSTITUT DE RECHERCHES INTERNATIONALES SERVIER
• University of Messina
• 臨床實驗概要; University of Messina
• 熊本大學
• 臨床實驗概要; 熊本大學
• The Royal Children's Hospital
• 臨床實驗概要; The Royal Children's Hospital
• Children's Hospital Boston
• 臨床實驗概要; Children's Hospital Boston
• Charite University
• 臨床實驗概要; Charite University
• Catholic University of the Sacred Heart
• 臨床實驗概要; Catholic University of the Sacred Heart
• Imperial College London
• 臨床實驗概要; Imperial College London
• Shriners Hospitals for Children
• 臨床實驗概要; Shriners Hospitals for Children
• Indiana University School of Medicine
• 臨床實驗概要; Indiana University School of Medicine
• Cedars-Sinai Medical Center
• 臨床實驗概要; Cedars-Sinai Medical Center
• Centre Hospitalier Universitaire de Nice
• 臨床實驗概要; Centre Hospitalier Universitaire de Nice
• National Institute of Neurological Disorders and Stroke
• 臨床實驗概要; National Institute of Neurological Disorders and Stroke
• Massachusetts General Hospital
• 臨床實驗概要; Massachusetts General Hospital
• 5大主要臨床簡介

附錄

• 簡稱
• 定義
• 調查方法
• 二級研究
• 關於GlobalData
• 諮詢方式
• 免責聲明
• 資訊來源

表格一覽

• 裘馨氏肌肉萎縮症 全球治療藥物市場, 臨床實驗 各地區
• 裘馨氏肌肉萎縮症 全球治療藥物市場, 臨床實驗 各國排名
• 裘馨氏肌肉萎縮症 全球治療藥物市場, 進行中的臨床實驗 各國排名
• 裘馨氏肌肉萎縮症 治療藥物的臨床實驗, 亞太地區, 前幾名國家
• 裘馨氏肌肉萎縮症 治療藥物的臨床實驗, 歐洲, 前五國
• 裘馨氏肌肉萎縮症 治療藥物的臨床實驗, 北美, 前幾名國家
• 裘馨氏肌肉萎縮症 治療藥物的臨床實驗, 中東及非洲, 前幾名國家
• 裘馨氏肌肉萎縮症 治療藥物的臨床實驗, 中南美, 前幾名國家
• 裘馨氏肌肉萎縮症 治療藥物的臨床實驗, 金磚四國 各國
• 裘馨氏肌肉萎縮症 治療藥物的臨床實驗, G7 各國
• 裘馨氏肌肉萎縮症 治療藥物市場, G7 各國, 臨床實驗 各臨床實驗狀態
• 裘馨氏肌肉萎縮症 治療藥物的臨床實驗, E7 各國
• 裘馨氏肌肉萎縮症 治療藥物市場, E7 各國, 臨床實驗 各臨床實驗狀態
• 裘馨氏肌肉萎縮症 全球治療藥物市場, 臨床實驗 各階段
• 裘馨氏肌肉萎縮症 全球治療藥物市場, 進行中的臨床實驗 各階段
• 裘馨氏肌肉萎縮症 全球治療藥物市場, 臨床實驗 各臨床實驗狀態
• 裘馨氏肌肉萎縮症 全球治療藥物市場, 一時中止的臨床實驗
• 裘馨氏肌肉萎縮症 全球治療藥物市場, 終止的臨床實驗
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗, 平均登錄對象人數趨勢
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗, 主要的贊助商
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗, 前幾名企業 各階段
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗, 臨床實驗 - 潛力治療藥物
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - PTC Therapeutics, Inc.
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - Santhera Pharmaceuticals Holding AG
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - GlaxoSmithKline plc
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - Genethon
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - AVI BioPharma Inc.
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - Acceleron Pharma, Inc.
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - Hugo W． Moser Research Institute at Kennedy Krieger, Inc.
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - Prosensa Therapeutics B．V.
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - Children's Healthcare of Atlanta Inc.
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - Kobe University
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - Nationwide Children's Hospital
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - Assistance Publique - Hopitaux de Paris
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - Cincinnati Children's Hospital Medical Center
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - 鈴鹿回生醫院
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - 刀根山醫院
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - INSTITUT DE RECHERCHES INTERNATIONALES SERVIER
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - University of Messina
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - 熊本大學
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - The Royal Children's Hospital
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - Children's Hospital Boston
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - Charite University
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - Catholic University of the Sacred Heart
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - Imperial College London
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - Shriners Hospitals for Children
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - Indiana University School of Medicine
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - Cedars-Sinai Medical Center
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - Centre Hospitalier Universitaire de Nice
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - National Institute of Neurological Disorders and Stroke
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗市場, 臨床實驗 - Massachusetts General Hospital

圖表一覽

• 裘馨氏肌肉萎縮症 全球治療藥物市場, 臨床實驗 各地區 (%)
• 裘馨氏肌肉萎縮症 全球治療藥物市場, 臨床實驗 各國排名
• 裘馨氏肌肉萎縮症 全球治療藥物市場, 進行中的臨床實驗 各國排名
• 裘馨氏肌肉萎縮症 治療藥物的臨床實驗, 亞太地區, 前幾名國家 (%)
• 裘馨氏肌肉萎縮症 治療藥物的臨床實驗, 歐洲, 前五國 (%)
• 裘馨氏肌肉萎縮症 治療藥物的臨床實驗, 北美, 前幾名國家 (%)
• 裘馨氏肌肉萎縮症 治療藥物的臨床實驗, 中南美, 前幾名國家 (%)
• 裘馨氏肌肉萎縮症 治療藥物的臨床實驗, G7 各國 (%)
• 裘馨氏肌肉萎縮症 治療藥物市場, G7 各國, 臨床實驗 各臨床實驗狀態
• 裘馨氏肌肉萎縮症 治療藥物的臨床實驗, E7 各國 (%)
• 裘馨氏肌肉萎縮症 治療藥物市場, E7 各國, 臨床實驗 各臨床實驗狀態
• 裘馨氏肌肉萎縮症 全球治療藥物市場, 臨床實驗 各階段 (%)
• 裘馨氏肌肉萎縮症 全球治療藥物市場, 進行中的臨床實驗 各階段
• 裘馨氏肌肉萎縮症 全球治療藥物市場, 臨床實驗 各臨床實驗狀態
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗, 平均登錄對象人數趨勢
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗, 主要的贊助商
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗, 前幾名企業 各階段
• 裘馨氏肌肉萎縮症 全球治療藥物臨床實驗, 臨床實驗 - 潛力治療藥物
• GlobalData 調查方法

Abstract

Duchenne Muscular Dystrophy Global Clinical Trials Review, H2, 2012

Summary

GlobalData's clinical trial report, "Duchenne Muscular Dystrophy Global Clinical Trials Review, H2, 2012" provides data on the Duchenne Muscular Dystrophy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Duchenne Muscular Dystrophy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Duchenne Muscular Dystrophy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Duchenne Muscular Dystrophy Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Duchenne Muscular Dystrophy, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

TOC

Table of Contents

Table of Contents 2

• List of Tables 5
• List of Figures 7
• Introduction 8
• Duchenne Muscular Dystrophy 8
• Report Guidance 8
• Clinical Trials by Region 9
• Clinical Trials by Country 10
• Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
• Top Five Countries Contributing to Clinical Trials in Europe 13
• Top Countries Contributing to Clinical Trials in North America 14
• Top Countries Contributing to Clinical Trials in Middle East and Africa 15
• Top Countries Contributing to Clinical Trials in Central and South America 16
• Clinical Trials by BRIC Nations 17
• Clinical Trials by G7 Nations 18
• Clinical Trials in G7 Nations by Trial Status 19
• Clinical Trials by E7 Nations 20
• Clinical Trials in E7 Nations by Trial Status 21
• Clinical Trials by Phase 22
• In Progress Trials by Phase 23
• Clinical Trials by Trial Status 24
• Unaccomplished Trials of Duchenne Muscular Dystrophy 25
• Subjects Recruited Over a Period of Time 27
• Prominent Sponsors 28
• Top Companies Participating in Duchenne Muscular Dystrophy Therapeutics Clinical Trials 30
• Prominent Drug Comparison 32
• Clinical Trial Profiles 33
• Clinical Trial Overview of Top Companies 33
• PTC Therapeutics, Inc. 33
• Clinical Trial Overview of PTC Therapeutics, Inc. 33
• GlaxoSmithKline plc 34
• Clinical Trial Overview of GlaxoSmithKline plc 34
• Sarepta Therapeutics, Inc. 35
• Clinical Trial Overview of Sarepta Therapeutics, Inc. 35
• Santhera Pharmaceuticals Holding AG 36
• Clinical Trial Overview of Santhera Pharmaceuticals Holding AG 36
• Prosensa Therapeutics B.V. 37
• Clinical Trial Overview of Prosensa Therapeutics B.V. 37
• Genethon 38
• Clinical Trial Overview of Genethon 38
• Acceleron Pharma, Inc. 39
• Clinical Trial Overview of Acceleron Pharma, Inc. 39
• Halo Therapeutics, LLC 40
• Clinical Trial Overview of Halo Therapeutics, LLC 40
• Shire Pharmaceuticals, Inc. 41
• Clinical Trial Overview of Shire Pharmaceuticals, Inc. 41
• Cardoz AB 42
• Clinical Trial Overview of Cardoz AB 42
• GlaxoSmithKline LLC 43
• Clinical Trial Overview of GlaxoSmithKline LLC 43
• Shenzhen Beike Biotechnology Co., Ltd. 44
• Clinical Trial Overview of Shenzhen Beike Biotechnology Co., Ltd. 44
• Summit Corporation plc 45
• Clinical Trial Overview of Summit Corporation plc 45
• Children's Healthcare of Atlanta Inc. 46
• Clinical Trial Overview of Children's Healthcare of Atlanta Inc. 46
• BioMarin Pharmaceutical Inc. 47
• Clinical Trial Overview of BioMarin Pharmaceutical Inc. 47
• Clinical Trial Overview of Top Universities / Institutes / Hospitals 48
• Kobe University 48
• Clinical Trial Overview of Kobe University 48
• Nationwide Children's Hospital 49
• Clinical Trial Overview of Nationwide Children's Hospital 49
• Cincinnati Children's Hospital Medical Center 50
• Clinical Trial Overview of Cincinnati Children's Hospital Medical Center 50
• The Royal Children's Hospital 51
• Clinical Trial Overview of The Royal Children's Hospital 51
• Assistance Publique - Hopitaux de Paris 52
• Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 52
• Radboud University Nijmegen Medical Centre 53
• Clinical Trial Overview of Radboud University Nijmegen Medical Centre 53
• University of Messina 54
• Clinical Trial Overview of University of Messina 54
• Kumamoto University 55
• Clinical Trial Overview of Kumamoto University 55
• Charite- Universitatsmedizin Berlin 56
• Clinical Trial Overview of Charite- Universitatsmedizin Berlin 56
• Children's Hospital Boston 57
• Clinical Trial Overview of Children's Hospital Boston 57
• The University of North Carolina 58
• Clinical Trial Overview of The University of North Carolina 58
• Catholic University of the Sacred Heart 59
• Clinical Trial Overview of Catholic University of the Sacred Heart 59
• Imperial College London 60
• Clinical Trial Overview of Imperial College London 60
• Shriners Hospitals for Children 61
• Clinical Trial Overview of Shriners Hospitals for Children 61
• University Hospital Freiburg 62
• Clinical Trial Overview of University Hospital Freiburg 62
• Indiana University School of Medicine 63
• Clinical Trial Overview of Indiana University School of Medicine 63
• The Ohio State University 64
• Clinical Trial Overview of The Ohio State University 64
• Cedars-Sinai Medical Center 65
• Clinical Trial Overview of Cedars-Sinai Medical Center 65
• Massachusetts General Hospital 66
• Clinical Trial Overview of Massachusetts General Hospital 66
• University of Rochester 67
• Clinical Trial Overview of University of Rochester 67
• Five Key Clinical Profiles 68

Appendix 116

• Abbreviations 116
• Definitions 116
• Research Methodology 117
• Secondary Research 117
• About GlobalData 118
• Contact Us 118
• Disclaimer 118
• Source 119

List of Tables

List of Tables

• Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9
• Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
• Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials, North America, Top Countries, 2012* 14
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 15
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 16
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials, BRIC Countries, 2012* 17
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials, G7 Countries, 2012* 18
• Duchenne Muscular Dystrophy Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials, E7 Countries, 2012* 20
• Duchenne Muscular Dystrophy Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
• Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22
• Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23
• Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
• Duchenne Muscular Dystrophy Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25
• Duchenne Muscular Dystrophy Therapeutics Market, Global, Terminated Clinical Trials, 2012* 26
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 27
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by PTC Therapeutics, Inc., 2012* 33
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 34
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarepta Therapeutics, Inc., 2012* 35
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Santhera Pharmaceuticals Holding AG, 2012* 36
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Prosensa Therapeutics B.V., 2012* 37
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Genethon, 2012* 38
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Acceleron Pharma, Inc., 2012* 39
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Halo Therapeutics, LLC, 2012* 40
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Pharmaceuticals, Inc., 2012* 41
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardoz AB, 2012* 42
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline LLC, 2012* 43
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Shenzhen Beike Biotechnology Co., Ltd., 2012* 44
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Summit Corporation plc, 2012* 45
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Healthcare of Atlanta Inc., 2012* 46
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by BioMarin Pharmaceutical Inc., 2012* 47
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Kobe University, 2012* 48
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Nationwide Children's Hospital, 2012* 49
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Cincinnati Children's Hospital Medical Center, 2012* 50
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by The Royal Children's Hospital, 2012* 51
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012* 52
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University Nijmegen Medical Centre, 2012* 53
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Messina, 2012* 54
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Kumamoto University, 2012* 55
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite- Universitatsmedizin Berlin, 2012* 56
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Hospital Boston, 2012* 57
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of North Carolina, 2012* 58
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Catholic University of the Sacred Heart, 2012* 59
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2012* 60
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Shriners Hospitals for Children, 2012* 61
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Freiburg, 2012* 62
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2012* 63
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by The Ohio State University, 2012* 64
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Cedars-Sinai Medical Center, 2012* 65
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012* 66
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2012* 67

List of Figures

List of Figures

• Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9
• Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
• Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 16
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials, G7 Countries (%), 2012* 18
• Duchenne Muscular Dystrophy Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials, E7 Countries (%), 2012* 20
• Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22
• Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23
• Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 27
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 30
• Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32
• GlobalData Methodology 117